ng-nitroarginine methyl ester has been researched along with Glaucoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araie, M; Ishii, K; Mayama, C; Ota, T; Tomidokoro, A | 1 |
| Chen, C; Guan, H; Hu, N; Xu, Y; Zhang, J; Zhu, J | 1 |
| Bucolo, C; Drago, F; Giuffrida, S | 1 |
| Chidlow, G; Osborne, NN; Safa, R; Syed, H | 1 |
| Kim, JH; Kim, YH; Park, CK; Park, SH | 1 |
5 other study(ies) available for ng-nitroarginine methyl ester and Glaucoma
| Article | Year |
|---|---|
Changes in optic nerve head circulation in response to vasoactive agents: intereye comparison in monkeys with experimental unilateral glaucoma.
Topics: Animals; Arginine; Blood Circulation; Blood Flow Velocity; Calcium Channel Blockers; Disease Models, Animal; Enzyme Inhibitors; Female; Glaucoma; Intraocular Pressure; Lasers, Gas; Macaca fascicularis; NG-Nitroarginine Methyl Ester; Nifedipine; Optic Disk; Piperazines; Regional Blood Flow; Tonometry, Ocular; Trabecular Meshwork | 2012 |
Altered expression of nNOS/NIDD in the retina of a glaucoma model of DBA/2J mice and the intervention by nNOS inhibition.
Topics: Age Factors; Animals; Apoptosis; Carrier Proteins; Disease Models, Animal; Enzyme Inhibitors; Ependymoglial Cells; Glaucoma; Membrane Proteins; Mice; Mice, Inbred DBA; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type I; Optic Nerve; Retinal Ganglion Cells; RNA, Messenger | 2013 |
Topical application of a nitric oxide synthase inhibitor reduces intraocular pressure in rabbits with experimental glaucoma.
Topics: Administration, Topical; Animals; Anterior Chamber; Area Under Curve; Chemistry, Pharmaceutical; Chymotrypsin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glaucoma; Injections; Intraocular Pressure; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Ophthalmic Solutions; Rabbits; Solvents | 2003 |
Sulfisoxazole, an endothelin receptor antagonist, protects retinal neurones from insults of ischemia/reperfusion or lipopolysaccharide.
Topics: Animals; Animals, Newborn; Anti-Infective Agents; Cell Death; Cells, Cultured; Coculture Techniques; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelins; Enzyme Inhibitors; Glaucoma; Lipopolysaccharides; Nerve Degeneration; Neurons; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Receptors, Endothelin; Reperfusion Injury; Retinal Degeneration; Sulfisoxazole; Thy-1 Antigens | 2006 |
Expression of neuronal nitric oxide synthase in the retina of a rat model of chronic glaucoma.
Topics: Animals; Blotting, Western; Cell Count; Chronic Disease; Glaucoma; Immunohistochemistry; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Retina; Retinal Ganglion Cells; Retinal Horizontal Cells | 2007 |